Status:
COMPLETED
"The Effects of Oxytocin on Patients With Borderline Personality Disorder"
Lead Sponsor:
Prof. Dr. Markus Heinrichs
Conditions:
Effects of Oxytocin on Borderline Personality Disorder
Borderline Personality Disorder
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
RCT. Two substudies (clinical and experimental). Main objective of the trial is to examine if oxytocin, compared to placebo shows any additional effect on the therapy achievements (outcome) of patient...
Eligibility Criteria
Inclusion
- Gender: Both, male and female
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Borderline personality disorder or major depression (clinical control group)
- Mini Mental Status Test \> 27 (capacity to consent)
Exclusion
- chronic or acute somatic health problems
- Schizophrenia
- Bipolar affective disorder
- pregnancy
- breast feeding
- neurological disorder
- allergy to antidegradants
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT01243658
Start Date
January 1 2011
End Date
April 1 2022
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albert-Ludwigs-Universität-Freiburg
Freiburg im Breisgau, Baden-Würtemberg, Germany, 79104